Benzinga | Oct 12, 2021 10:59AM EDT

Noble Capital Markets Initiates Coverage On Axcella Health with Outperform Rating, Announces Price Target of $6

Noble Capital Markets analyst Robert LeBoyer initiates coverage on Axcella Health (NASDAQ:AXLA) with a Outperform rating and announces Price Target of $6.